Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 18:49:52 - browse：8137

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Zyn nicotine pouches become unlikely player in latest culture war

WSS

Medicare Advantage insurers face 0.2% cut to 2025 payments

How medical schools plan to diversify without affirmative action

White House pharmacy plagued with problems, investigation finds

FDA approves updated Covid vaccines

Investment in vaccine development is lagging, report finds

FDA proposes changes to key medical devices approval pathway

focus

Wikipedia

hotspot

Heart attack and stroke risk calculators need revising

PEPFAR is under serious threat — and so is global health

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Philips to halt sales of sleep apnea machines in U.S.

Dobbs anniversary: the lost opportunity of abortion as health care

Venture capital firm's plans to take over Akron hospital face hurdles

Trump demands the U.S. pay no more for drugs than other countries … again

WATCH: Why do bright lights make us see spots?

Jerome Adams on the need for new antivirals for Covid

New Covid vaccine is recommended for everyone 6 months or older

explore

Health Care Service Corp to buy Cigna Medicare Advantage plans

Popular nasal decongestant doesn't actually relieve congestion

How medical schools plan to diversify without affirmative action

Reconstructing family trees of blood cells may help predict disease

IRA could hurt research into orphan drugs for rare diseases

Hospitals consider fixing cancer drug shortages on their own

focus

leisure time

knowledge

focus